My Quote Request
No products added yet
6505-01-266-7490
20 Products
FA BORDETELLA PERTUSSIS
ANTIGEN,PERTUSSIS
NSN, MFG P/N
6505012667490
NSN
6505-01-266-7490
FA BORDETELLA PERTUSSIS
ANTIGEN,PERTUSSIS
NSN, MFG P/N
6505012667490
NSN
6505-01-266-7490
MFG
DIFCO LABORATORIES
Description
SPECIAL FEATURES: ONE 5 ML BOTTLE OF BORDETELLA PERTUSSIS ANTIGEN; FOR USE IN DIRECT FLUORESCENT ANTIBODY TESTING
UNIT PACKAGE QUANTITY: 1
UNIT PACKAGE TYPE: BOTTLE
Related Searches:
2359-56-6
ANTIGEN,PERTUSSIS
NSN, MFG P/N
6505012667490
NSN
6505-01-266-7490
MFG
DIFCO LABORATORIES
Description
SPECIAL FEATURES: ONE 5 ML BOTTLE OF BORDETELLA PERTUSSIS ANTIGEN; FOR USE IN DIRECT FLUORESCENT ANTIBODY TESTING
UNIT PACKAGE QUANTITY: 1
UNIT PACKAGE TYPE: BOTTLE
Related Searches:
K-DUR
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505012668634
NSN
6505-01-266-8634
K-DUR
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505012668634
NSN
6505-01-266-8634
MFG
SCHERING-PLOUGH CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1500.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 20 MEQ POTASSIUM EQUIVALENT; COMPRISED OF MICROENCAPSULATED CRYSTALS; 100 TABLETS
THERAPEUTIC EQUIVALENT: K-DUR BY KEY PHARMACEUTICALS
Related Searches:
K-DUR TABLETS
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505012668634
NSN
6505-01-266-8634
K-DUR TABLETS
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505012668634
NSN
6505-01-266-8634
MFG
SCHERING-PLOUGH CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1500.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 20 MEQ POTASSIUM EQUIVALENT; COMPRISED OF MICROENCAPSULATED CRYSTALS; 100 TABLETS
THERAPEUTIC EQUIVALENT: K-DUR BY KEY PHARMACEUTICALS
Related Searches:
NDC00085-0787-01
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505012668634
NSN
6505-01-266-8634
NDC00085-0787-01
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505012668634
NSN
6505-01-266-8634
MFG
SCHERING-PLOUGH CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1500.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 20 MEQ POTASSIUM EQUIVALENT; COMPRISED OF MICROENCAPSULATED CRYSTALS; 100 TABLETS
THERAPEUTIC EQUIVALENT: K-DUR BY KEY PHARMACEUTICALS
Related Searches:
NDC00085-0787-81
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505012668634
NSN
6505-01-266-8634
NDC00085-0787-81
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505012668634
NSN
6505-01-266-8634
MFG
SCHERING-PLOUGH CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1500.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 20 MEQ POTASSIUM EQUIVALENT; COMPRISED OF MICROENCAPSULATED CRYSTALS; 100 TABLETS
THERAPEUTIC EQUIVALENT: K-DUR BY KEY PHARMACEUTICALS
Related Searches:
NDC00093-5311-01
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505012668634
NSN
6505-01-266-8634
NDC00093-5311-01
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505012668634
NSN
6505-01-266-8634
MFG
LEMMON CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1500.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 20 MEQ POTASSIUM EQUIVALENT; COMPRISED OF MICROENCAPSULATED CRYSTALS; 100 TABLETS
THERAPEUTIC EQUIVALENT: K-DUR BY KEY PHARMACEUTICALS
Related Searches:
NDC00245-0058-01
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505012668634
NSN
6505-01-266-8634
NDC00245-0058-01
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505012668634
NSN
6505-01-266-8634
MFG
UPSHER-SMITH LABORATORIES INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1500.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 20 MEQ POTASSIUM EQUIVALENT; COMPRISED OF MICROENCAPSULATED CRYSTALS; 100 TABLETS
THERAPEUTIC EQUIVALENT: K-DUR BY KEY PHARMACEUTICALS
Related Searches:
NDC00245-0058-11
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505012668634
NSN
6505-01-266-8634
NDC00245-0058-11
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505012668634
NSN
6505-01-266-8634
MFG
UPSHER-SMITH LABORATORIES INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1500.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 20 MEQ POTASSIUM EQUIVALENT; COMPRISED OF MICROENCAPSULATED CRYSTALS; 100 TABLETS
THERAPEUTIC EQUIVALENT: K-DUR BY KEY PHARMACEUTICALS
Related Searches:
NDC58177-0202-04
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505012668634
NSN
6505-01-266-8634
NDC58177-0202-04
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505012668634
NSN
6505-01-266-8634
MFG
ETHEX CORP SUB OF K-V PHARMACEUTICAL CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1500.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 20 MEQ POTASSIUM EQUIVALENT; COMPRISED OF MICROENCAPSULATED CRYSTALS; 100 TABLETS
THERAPEUTIC EQUIVALENT: K-DUR BY KEY PHARMACEUTICALS
Related Searches:
NDC58177-0202-11
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505012668634
NSN
6505-01-266-8634
NDC58177-0202-11
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505012668634
NSN
6505-01-266-8634
MFG
ETHEX CORP SUB OF K-V PHARMACEUTICAL CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1500.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 20 MEQ POTASSIUM EQUIVALENT; COMPRISED OF MICROENCAPSULATED CRYSTALS; 100 TABLETS
THERAPEUTIC EQUIVALENT: K-DUR BY KEY PHARMACEUTICALS
Related Searches:
NDC59930-1714-01
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505012668634
NSN
6505-01-266-8634
NDC59930-1714-01
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505012668634
NSN
6505-01-266-8634
MFG
WARRICK PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1500.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 20 MEQ POTASSIUM EQUIVALENT; COMPRISED OF MICROENCAPSULATED CRYSTALS; 100 TABLETS
THERAPEUTIC EQUIVALENT: K-DUR BY KEY PHARMACEUTICALS
Related Searches:
NDC62037-0720-01
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505012668634
NSN
6505-01-266-8634
NDC62037-0720-01
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505012668634
NSN
6505-01-266-8634
MFG
ANDRX PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1500.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 20 MEQ POTASSIUM EQUIVALENT; COMPRISED OF MICROENCAPSULATED CRYSTALS; 100 TABLETS
THERAPEUTIC EQUIVALENT: K-DUR BY KEY PHARMACEUTICALS
Related Searches:
0343-80
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012669387
NSN
6505-01-266-9387
0343-80
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012669387
NSN
6505-01-266-9387
MFG
3M COMPANY HEALTH CARE/MFG
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: LONG ACTION MEHTOD:EXTENDED RELEASE;SCORING CHARACTERISTICS:HALF-SCORED;
THERAPEUTIC EQUIVALENT: THEOLAIR SR BY RIKER LABS.,INC.
Related Searches:
NDC00089-0343-80
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012669387
NSN
6505-01-266-9387
NDC00089-0343-80
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012669387
NSN
6505-01-266-9387
MFG
3M COMPANY HEALTH CARE/MFG
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: LONG ACTION MEHTOD:EXTENDED RELEASE;SCORING CHARACTERISTICS:HALF-SCORED;
THERAPEUTIC EQUIVALENT: THEOLAIR SR BY RIKER LABS.,INC.
Related Searches:
THEOLAIR TABLETS
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012669387
NSN
6505-01-266-9387
THEOLAIR TABLETS
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012669387
NSN
6505-01-266-9387
MFG
3M COMPANY HEALTH CARE/MFG
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: LONG ACTION MEHTOD:EXTENDED RELEASE;SCORING CHARACTERISTICS:HALF-SCORED;
THERAPEUTIC EQUIVALENT: THEOLAIR SR BY RIKER LABS.,INC.
Related Searches:
0341-80
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012669388
NSN
6505-01-266-9388
0341-80
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012669388
NSN
6505-01-266-9388
MFG
3M COMPANY HEALTH CARE/MFG
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: LONG ACTION METHOD:EXTENDED RELEASE;SCORING CHARACTERISTICS:HALF-SCORED;
THERAPEUTIC EQUIVALENT: THEOLAIR SR BY RIKER LABS.,INC.
Related Searches:
NDC00089-0341-80
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012669388
NSN
6505-01-266-9388
NDC00089-0341-80
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012669388
NSN
6505-01-266-9388
MFG
3M COMPANY HEALTH CARE/MFG
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: LONG ACTION METHOD:EXTENDED RELEASE;SCORING CHARACTERISTICS:HALF-SCORED;
THERAPEUTIC EQUIVALENT: THEOLAIR SR BY RIKER LABS.,INC.
Related Searches:
THEOLAIR TABLETS
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012669388
NSN
6505-01-266-9388
THEOLAIR TABLETS
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012669388
NSN
6505-01-266-9388
MFG
3M COMPANY HEALTH CARE/MFG
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: LONG ACTION METHOD:EXTENDED RELEASE;SCORING CHARACTERISTICS:HALF-SCORED;
THERAPEUTIC EQUIVALENT: THEOLAIR SR BY RIKER LABS.,INC.
Related Searches:
15820
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505012669389
NSN
6505-01-266-9389
MFG
SOLOPAK MEDICAL PRODUCTS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,SOLO PAK LABS
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL,SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 25
